Abstract:Aims: CD36 , an important gene involved in cholesterol and fatty acid metabolism,, has been associated with many metabolic-related traits, including diabetes, hypertension, and obesity in different populations. However, the association of this gene with metabolic syndrome (MS) has not been well-studied. We aimed to investigate the association of CD36 with the risk of MS and longitudinal changes of its components in among participants of the Rural Chinese Cohort Study (RCCS). Materials and Methods: The RCCS enrolled 20,194 participants aged 2 18 years old between July of 2007 and August of 2008. A total of 17,265 participants (response rate 85.5%) were examined in the follow-up survey between July of 2013 and October of 2014. During the six years, 729 new incident cases of MS were ascertained. We conducted a nested case-control study within the RCCS. Specifically, 408 MS randomly cases and 408 one-to-one matched controls were included in the current study. In addition to follow-up time, non-MS controls were matched to MS cases on age, gender, marital status, and residence village. Human genomic DNA was extracted using a standard method from blood samples collected at the baseline. After quality control, 4 single nucleotide polymorphisms (SNPs) within the CD36 were successfully genotyped. MS was defined according to the 2009 criteria proposed by IDF and AHA/NHLBI. Multivariate conditional logistic regression was used to determine additive associations of SNPs and SNP-haplotype with MS adjusting for body mass index (BMI), smoking, drinking, and physical activity at baseline. Multivariate linear regression models were conducted among the control group to examine association of SNPs and SNP-haplotypes with MS components, controlling for age, gender, BMI, smoking, drinking and physical activity. Multiple testing was corrected by false positive discovery rate (FDR) method. Results: Two SNPs, rs7755 and rs1049673, were associated with risk for MS. Per minor allele increase in rs7755 and rs1049673 was associated with 2.29 (95% confidence interval [CI]: 1.24-4.24, p =0.008) and 2.30 (95% CI: 1.24-4.26, p =0.008) times higher odds of MS, respectively. In addition, rs1194197 was associated with changes of triglycerides level (β=0.151, p =0.014), and rs7755 (β=-0.065, p =0.028) and rs1049673 (β=-0.067, p =0.025) were associated with changes of high density lipoprotein cholesterol in the control group. One haplotype of the four SNPs, AGAG, was associated with the change of waist circumference (β=-1.773, p =0.048). Conclusions: We identified important SNPs and SNP-haplotypes of the CD36 associated with MS and changes of MS components in a Han Chinese population.

Progress on association between low-density lipoprotein receptor and metabolic syndrome

Inverse Relationship Between Serum Lipoxin A4 Level And The Risk Of Metabolic Syndrome In A Middle-Aged Chinese Population

Abstract P114: Genetic Polymorphisms of CD36 Associated with Metabolic Syndrome in Chinese Han Population: A Nested Case-Control Study

The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling

Lipoprotein lipase and metabolic syndrome

Relationship between Metabolic Syndrome and Chronic Kidney Disease

The Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Lipid Metabolism, Glucose Homeostasis and Inflammation

The changes and clinical significance of serum ox-LDL in the elderly with metabolic syndrome

Associations Between Obesity-Related Gene MC4R rs17782313 Locus Polymorphism and Components of Metabolic Syndrome: A Systematic Review and Meta-Analysis

Dysregulation of long non-coding RNA ZFAS1 in children with obesity and its predictive value for metabolic syndrome

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Clinical investigation of lipopolysaccharide in the persistence of metabolic syndrome (MS) through the activation of GRP78-IRE1α-ASK1 signaling pathway

Relationships of Lipoprotein (a) with the Metabolic Syndrome in Type 2 Diabetes Mellitus

Role of Metabolic Syndrome and Its Components As Mediators of the Genetic Effect on Type 2 Diabetes: A Family-Based Study in China

Association of Vitamin D Receptor Polymorphisms with Metabolic Syndrome-Related Components: A Cross-Sectional Study

Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases

Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study

Association Between Metabolic Syndrome and the Development of Non-Alcoholic Fatty Liver Disease

Controversies and Consensus Concerning Metabolic Syndrome

Small dense low density lipoprotein predominance in patients with type 2 diabetes mellitus using Mendelian randomization

Associations Between Liver X Receptor Polymorphisms and Blood Lipids: A Systematic Review and Meta-Analysis